Aims Amphetamine intake is associated with acute vascular syndromes. Since these events are caused by arterial thrombosis and this in turn is triggered by tissue factor (TF), this study examines whether amphetamines regulate TF in human endothelial cells. Methods and results Amphetamine (10(-7)-10(-4) mol/L) enhanced thrombin-and tumour necrosis factor (TNF)-alpha-induced as well as basal TF expression (P = 0.029, 0.0003, and 0.003 at maximal concentration), and TNF-alpha-induced plasminogen activator inhibitor (PAI)-1 expression (P = 0.003), whereas tissue factor pathway inhibitor expression was impaired (P = 0.008). Similarly, 3,4-methylenedioxymethamphetamine (10(-7)-10(-4) mol/L) enhanced TF expression (P = 0.046). These effects were paralleled by an increased TF activity (P = 0.002); moreover, clotting time of human plasma was accelerated by supernatant from amphetamine-treated cells (P = 0.03). Amphetamine enhanced TF mRNA expression via phosphorylation of the mitogen-activated protein kinases (MAPKs) extracellular signal-regulated kinase (ERK) and p38 (P = 0.03 and 0.033), but not c-Jun NH(2)-terminal kinase (JNK; P = 0.81). The effect of amphetamine on TF expression was abrogated by the dopamine D4 receptor antagonists L-745,870 and L-750,667, but not D2 or D3 receptor antagonists; furthermore, L-745,870 blunted the amphetamine-induced activation of ERK and p38, but not JNK. Conclusion Amphetamines induce endothelial TF expression via stimulation of dopamine D4 receptor and activation of the MAPKs p38 and ERK. These effects occur at clinically relevant amphetamine concentrations and may account for the increased incidence of acute vascular syndromes after amphetamine consumption. 
Introduction
In the Western civilization, intake of psychostimulants such as amphetamine and methylenedioxymethamphetamine (MDMA, "Ecstasy") has risen dramatically over the past decade; as a consequence, this phenomenon has now turned into a major public burden (1) . The problem is aggravated by the fact that the majority of consumers are young (≤ 45 years) and thus often faced with unexpected acute cardiovascular events (2) . Indeed, numerous publications report amphetamineassociated acute vascular syndromes including myocardial infarction and ischemic stroke (3) (4) (5) (6) (7) (8) .
The pathogenesis of amphetamine-related acute cardiovascular events is still uncertain. Vasospasm and prothrombotic state have been postulated as etiologic factors, but no solid evidence is available to support these assumptions (3, 4, 9) . The combination of vasospasm and thrombosis does indeed seem to play a role in coronary artery occlusion, indicating a dynamic interaction of vasoconstriction and thrombus formation in acute vascular syndromes (10). Further, substances suspected to promote vasospasm, such as histamine and cocaine, are known to induce the endothelial expression of tissue factor (TF) (11, 12) . TF is the main trigger of coagulation and crucially involved in arterial thrombus formation, the central event in acute vascular syndromes (13). In this context, it is important to note that amphetamines are known to activate MAP kinases, the major regulators of endothelial TF expression, in neuronal cells (14) . Based on these facts, we hypothetized that amphetamine may induce TF expression. Hence, this study was designed to examine the effect of amphetamines on TF expression in human vascular endothelial cells.
Cell culture
Human aortic endothelial cells (HAECs; Clonetics, Allschwil, Switzerland) were cultured as described (15). Cells were grown to confluence and were then serum withdrawn for 24 hrs by using EBM medium (Cambrex) supplemented with 0.5% FCS, before stimulation with 5 ng/mL TNF-α (R&D, Minneapolis, MN) or 1 U/mL thrombin (Sigma-Aldrich, Buchs, Switzerland) ( Table 1) (Table 1) . Cytotoxicity was assessed with a colorimetric assay to detect lactate dehydrogenase release (Roche, Basel, Switzerland). The use of MDMA in this study was approved by the Swiss Health Authority (reference: AB-8/5-BetmG-07.001315).
Western blot
Protein expression was determined by Western blot analysis as described (16) .
Antibodies against human TF and tissue factor pathway inhibitor (TFPI; both from American Diagnostica, Stamford, CT) were used at 1:2000 dilution. Antibody against plasminogen activator inhibitor (PAI-1; Santa Cruz) was applied at 1:4000 dilution. 
Real-time PCR
Total RNA was extracted from HAEC using TRIzol Reagent (Invitrogen). The amplification program consisted of 1 cycle at 95˚C for 10 min, followed by 35 cycles with a denaturing phase at 95˚C for 30 s, an annealing phase at 60°C for 1 min and an elongation phase at 72˚C for 1 min. A melting curve analysis was performed after amplification to verify the accuracy of the amplicon. PCR products were also analyzed on an ethidium bromide stained 1.5% agarose gel. In each realtime PCR run, a calibration curve was included that was generated from serial dilutions of the respective purified amplicons. TF mRNA stability was assessed in the presence of the transcriptional inhibitor actinomycin D (10 ug/mL, Sigma-Aldrich, Buchs, Switzerland), which was added 2 hrs after TNF-α stimulation. Cells were harvested for RNA extraction at various time-points (0-3 hrs) following actinomycin D treatment. The copy numbers for TF obtained in the real-time PCR analysis were normalized to those of L28, and the values are presented as percent of the TNF-α alone group.
Gene silencing through siRNA transfection
Three siRNA sequences specific for the human dopamine receptor 4 (D4) were applied for knocking down D4 expression using the N-TER™ Nanoparticle siRNA Transfection System (Sigma, Saint Louis, USA). These siRNA sequences were as 
TF activity
TF activity was analyzed at the luminal surface of adherent endothelial cells and in whole cell lysates of HAEC using a colorimetric assay (American Diagnostica).
TF/FVIIa converted factor X to factor Xa, which was measured by its ability to metabolize a chromogenic substrate. A standard curve with lipidated human TF was performed to assure that measurements were taken in the linear range of detection.
Clotting time
Clotting time was assessed using a Start fibrometer. 50 μL of supernatant from HAECs were harvested and incubated with 50 μL of citrated human plasma for 1 min. Coagulation was initiated by the addition of 25 mM calcium chloride followed by analysis of clotting time.
Statistics
Differences between mean data were compared by the non parametric Mann- 
Results

Amphetamines enhance TF protein expression and activity
HAECs were stimulated with TNF-α (5 ng/ml) or thrombin (1 U/mL) for 5 hours in the presence or absence of amphetamines (Table 1) . Amphetamine (10 -7 -10 -4 mol/L) enhanced TNF-α induced TF expression in a concentration-dependent manner reaching a 1.8-fold induction (n=7; p=0.0003; Mann Whitney test; Figure 1A , Table 2 ). Similarly, amphetamine enhanced thrombin induced TF expression by 1.6-fold (n=4; p=0.029; Mann Whitney test; Figure 1C ; Table 2 ) and basal TF expression by 2.2-fold (n=7; p=0.003; Mann Whitney test; Figure 1D ; Table 2 ). Similar to amphetamine, MDMA (10 -7 -10 -4 mol/L) enhanced TF expression by 1.7-fold at maximum concentration as compared to TNF-α alone (n=4; p=0.046; Mann Whitney test; Figure 1B ; Table 2 ). The effect of amphetamine and MDMA on TF protein expression was paralleled by an increased TF surface activity both in TNF-α stimulated cells (n=5-6; p=0.002 and p=0.008, respectively; Mann Whitney test;
Figure 2A and 2B; Table 2 ) and under basal conditions (n=6; p=0.002; Mann Whitney test; Figure 2D ; Table 2 ). Amphetamine induced a similar relative increase in TF surface activity and TF whole cell activity (n=5; p=0.004; Mann Whitney test; Figure   2C ; Table 2 ).
Amphetamines are not toxic
To control for toxic effects, HAECs were treated with increasing concentrations of amphetamine or MDMA for 6 hours. Morphological examination did not reveal any changes (n=9; data not shown); moreover, no signs of toxicity were detected by LDH release for any concentration of amphetamine or MDMA used (n=9; data not shown).
Amphetamine accelerates clotting time of human plasma
To assess the functional relevance of amphetamine induced TF expression, the effect of supernatant from amphetamine treated HAECs on clotting time of human plasma was assessed. Clotting time was accelerated by supernatant from cells treated with amphetamine both under basal conditions (n=6; p=0.03; Mann Whitney test; Supplemental Figure 1 ; Table 2 ) and after stimulation with TNF-α (n=6; p=0.002; Mann Whitney test; Supplemental Figure 1 ; Table 2 ).
Amphetamine impairs TFPI and increases PAI-1 expression
Increasing concentrations of amphetamine (10 -7 -10 -4 mol/L) inhibited expression of TFPI in TNF-α and thrombin stimulated HAECs resulting in a 45% and 36% reduction, respectively (n=4-5; p=0.008 and p=0.03, respectively; Mann Whitney test; Figure 3B and 3C; Table 2 ). A similar effect was observed under basal conditions (n=4; p=0.03; Mann Whitney test; Figure 3A ; Table 2 ). In contrast, amphetamine (10 -4 mol/L) increased endothelial PAI-1 expression following TNF-α stimulation (n=6; p=0.003; Mann Whitney test; Table 2 ).
Amphetamine enhances TF mRNA expression without affecting mRNA stability
Real-time PCR demonstrated that TF mRNA expression was induced after 2 hours of TNF-α stimulation (n=4; p=0.029; Mann Whitney test; Figure 4A ). Treatment with amphetamine enhanced TNF-α induced TF mRNA expression in a concentration-dependent manner reaching a maximal induction of 2.1-fold (n=4; p=0.032; Mann Whitney test; Figure 4A ; Table 2 ). Amphetamine did not affect the stability of TF mRNA under these conditions (n=4; Figure 4B ).
Amphetamine enhances MAP kinase activation
To assess whether amphetamine alters MAP kinase activation, HAECs were examined at different time points after cytokine stimulation. The MAP kinases p38, ERK, and JNK were transiently activated by TNF-α (n=4; Figure 6A ). Amphetamine enhanced phosphorylation of p38 and ERK (n=4-7; p=0.033 and p=0.03, respectively; Mann Whitney test; Figure 5A and B; Table 2 ), while that of JNK remained unaffected (n=4; p=0.81; Mann Whitney test; Figure 5A Table 2 ). When the D4 receptor gene was silenced through siRNA transfection, the effect of amphetamine on TF expression was abrogated, whereas non targeting siRNA had no effect on amphetamine induced TF expression Amphetamine consumption can lead to death due to cardiovascular events and is becoming an increasingly serious worldwide concern. Indeed, data from more than 30 case reports and 8 epidemiologic studies support this tendency.
Amphetamine associated adverse cardiovascular events mostly occur in relatively young individuals with no previous history of cardiovascular disease. Consistent with this observation, myocardial ischemia with angiographically normal coronary arteries is documented in amphetamine consumers (2, 17) . A recent report described severe anterior myocardial infarction with pump failure due to proximal thrombotic occlusion of the LAD in a 28 year old amphetamine consumer (18) . Similar reports have demonstrated intravascular thrombosis, either angiographically or in postmortem examination, in such patients (18, 19) . In the present study, amphetamines are shown to induce TF expression and surface activity in human endothelial cells; this effect occurred at the transcriptional level and was mediated through the dopamine D4 receptor leading to activation of the MAP kinases p38 and ERK. Since TF is the key trigger of thrombosis, our observations offer a potential mechanism for the occurrence of acute vascular syndromes in amphetamine consumers.
The concentrations applied in the present study are within the plasma range observed in vivo; indeed, a plasma concentration of 5 x 10 -6 mol/L (1.1 μg/ml) was measured 6 hours following MDMA intake in a subject who developed massive thrombosis of the right coronary artery (19) . However, there is a large variability of amphetamine plasma levels in patients presenting to the emergency department, and up to 100-fold higher plasma concentrations in the range of 0.4 -84.0 μg/ml for -5 mol/L) for amphetamine were measured in amphetamine victims (20) .
In (38, 39) . Not surprisingly, MAP kinases, in particular the ERK pathway, have been described as a key molecular process in selective brain regions in response to amphetamine, and pharmacological manipulation of the ERK pathway has been proposed as a potential treatment strategy for drug addiction (40) .
The present in vitro study has several limitations. We have not studied all the mechanism potentially influencing dopamine receptor signalling. Thus, further studies are needed to understand the molecular mechanism by which dopamine receptor signalling is involved in the regulation of haemostasis and vascular biology.
Moreover, animal and clinical studies need to clarify whether an increased TF activity indeed accounts for the effects of amphetamines on thrombus formation in vivo.
In summary, this study demonstrates that amphetamine leads to an increase in endothelial TF expression and activity with a parallel decrease in TFPI expression. Table 1 Cell culture HAEC E x p e r im e n t a l d is h e s Cell culture HAEC 24-72 hrs C e ll c o n f lu e n c e S t a r t e x p e r im e n t S t o p e x p e r im e n t M e a s u r e m e n t s S t a t is t ic a l a n a l y s is 
